Analyst Ratings for Pernix Therapeutics (PTX) [Sells]

PTX Rating Summary

PTX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on PTX
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $4.15 (-11.7%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
1/6/2014 Cantor Fitzgerald Downgrade Sell
(Hold)
2.00
(N/A)
2.41 4.70 95.02% Details